What is the official website of NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company ?

The official website of NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company is http://www.nutrichem.de.

What is NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company's cybersecurity risk score?

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company has an AI-generated cybersecurity risk score of 752 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company experienced?

According to Rankiteo, NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company been affected by any supply chain cyber incidents ?

According to Rankiteo, NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company have SOC 2 Type 1 certification ?

According to Rankiteo, NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company is not certified under SOC 2 Type 1.

Does NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company have SOC 2 Type 2 certification ?

According to Rankiteo, NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company does not hold a SOC 2 Type 2 certification.

Does NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company comply with GDPR ?

According to Rankiteo, NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company is not listed as GDPR compliant.

Does NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company have PCI DSS certification ?

According to Rankiteo, NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company does not currently maintain PCI DSS compliance.

Does NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company comply with HIPAA ?

According to Rankiteo, NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company is not compliant with HIPAA regulations.

Does NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company have ISO 27001 certification ?

According to Rankiteo,NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company operate in ?

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company have ?

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company employs approximately 73 people worldwide.

Does NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company own any subsidiaries ?

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company presently has no subsidiaries across any sectors.

How many LinkedIn followers does NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company have ?

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company's official LinkedIn profile has approximately 2,193 followers.

What is the NAICS classification code for NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company ?

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company have a Crunchbase profile ?

No, NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company does not have a profile on Crunchbase.

Does NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company have a LinkedIn profile ?

Yes, NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/nutrichem-de.

How many cybersecurity incidents has NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company experienced ?

As of September 26, 2026, Rankiteo reports that NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company has not experienced any cybersecurity incidents.

How many peer or competitor companies does NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company have ?

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company has an estimated 5,769 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

NDPGBBC

Boost Score +25 with badge (5 left)

752

/1000

Fair

777

/1000

Fair

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company Vendor Cyber Rating & Cyber Score

nutrichem.de

Add Your Compliance Badge

NUTRICHEM DIÄT + PHARMA GMBH and its subsidiary inkospor® are part of the B. Braun Group of companies. NUTRICHEM DIÄT + PHARMA GMBH develops, manufactures, and packages high-quality nutritional and pharmaceutical products with state-of-the-art technology for clients across the globe. Backed by a powerhouse R&D department, we help our clients manufacture nutritional products in the areas of: -Enteral Nutrition -OEM -Sports Nutrition NUTRICHEM had its early roots in the raw materials industry in 1977 and over the years has developed into a major food manufacturer in Germany that has penetrated beyond clinical nutrition into the world of sports nutrition. Over the years, NUTRICHEM was taken over by B. Braun Melsungen AG in order to

NDPGBBC

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

NDPGBBC Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for NDPGBBC

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company in 2026.

Incident Types NDPGBBC vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company in 2026.

Incident History - NDPGBBC (X = Date, Y = Severity)

Loading…

SUBSIDIARY

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company Subsidiaries

NDPGBBC

Pharmaceutical Manufacturing

Website: http://www.nutrichem.de

Company Size: 201-500 employees

B. Braun GroupMedical Equipment Manufacturing

B. Braun Medical Inc. (US)Medical Equipment Manufacturing

B. Braun New VenturesMedical Equipment Manufacturing

B. Braun Vet CareTierärztliche Leistungen

Aesculap AcademyEducation

Loading…

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company Similar Companies

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Johnson & Johnson Innovative Medicine

jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Loading…

NEWS

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-96795

SUMMARY

Horilla is an HR and CRM software. Prior to 2.0.0, HorillaListView.export_data in horilla_views/generic/cbv/views.py accepts an authenticated user's columns POST parameter, takes field_tuple[1], interpolates it into dynamic_fn_str as Python source, and passes the generated function definition to exec(). A crafted string that remains valid under ast.literal_eval can inject Python syntax into a default argument evaluated during function definition, allowing arbitrary operating-system commands to execute with the application process privileges, including root privileges in the shipped Docker image. This issue is fixed in version 2.0.0.

Published

Date2026-09-25

Updated

Date2026-09-25

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

CVE-2026-86066

SUMMARY

Horilla is an HR and CRM software. Prior to 2.0.0, approve_validate_attendance_request at /attendance/approve-validate-attendance-request/ changes attendance_validated, is_validate_request_approved, approved_by, and related pending-request state through an HTTP GET before calling attendance.save(), so Django does not require CSRF validation for the action. An unauthenticated attacker can cause a logged-in manager with attendance.change_attendance to make a top-level request that carries the manager's SameSite=Lax session cookie, silently approving attendance with the victim's privileges and attributing the approval to the victim in the audit trail. This issue is fixed in version 2.0.0.

Published

Date2026-09-25

Updated

Date2026-09-25

RISK INFORMATION (Score: )

cvss4

Base Score: 5.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:A/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-57449

SUMMARY

Actual is a local-first personal finance tool. Prior to 26.7.0, Actual Sync Server's CORS proxy is intended to let authenticated users fetch resources only from repositories listed in the official plugin allowlist. When `ACTUAL_GITHUB_TOKEN` is configured, the proxy automatically attaches the server's GitHub token to GitHub requests. The GitHub API allowlist check uses a raw `startsWith()` prefix test for `/repos/{owner}/{repo}` without requiring a path boundary after the repository name. If an allowlisted public plugin repository is `https://github.com/acme/plugin`, the proxy also accepts GitHub API URLs. Those URLs are outside the allowlisted repository but still pass because their API path starts with `/repos/acme/plugin`. The proxy then forwards the request with the server's `ACTUAL_GITHUB_TOKEN`, allowing any authenticated Actual user to read private GitHub resources reachable by that token. Version 26.7.0 fixes the issue.

Published

Date2026-09-25

Updated

Date2026-09-25

RISK INFORMATION (Score: )

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://github.com/actualbudget/actual/security/advisories/GHSA-m62c-5q34-f3cf

CVE-2026-92842

SUMMARY

The convert.base64-encode, convert.quoted-printable-encode and convert.quoted-printable-decode stream filters accept a line-break-chars option whose length is tracked separately from the string itself. The filter constructors duplicate the value with pestrdup(), which stops at the first NUL byte, while keeping the original length. When the filter later emits a line break it copies the recorded length out of the truncated allocation, reading past its end and placing adjacent heap bytes into the filter output.

Published

Date2026-09-25

Updated

Date2026-09-25

RISK INFORMATION (Score: 5.9)

cvss3

Base Score: 5.9

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

2.2

REFERENCES

https://github.com/php/php-src/security/advisories/GHSA-88hq-2827-7pg6

CVE-2026-91768

SUMMARY

The IPv6 branch of the FastCGI client access check compares only the first 12 bytes of a 16-byte IPv6 address, so listen.allowed_clients matches on a /96 prefix instead of the exact address. An attacker who can source an address sharing the first 96 bits with an allowed one passes the check and reaches the FastCGI endpoint.

Published

Date2026-09-25

Updated

Date2026-09-25

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://github.com/php/php-src/security/advisories/GHSA-62xp-839h-2637

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company Vendor Cyber Rating & Cyber Score

NDPGBBC A.I CyberSecurity Scoring

NUTRICHEM DIÄT + PHARMA GMBH - a B. Braun Company CyberSecurity News & History

NDPGBBC Company Scoring based on AI Models